Recall Record

Cranbury, NJ, United States

Prinston Pharmaceutical Inc recalls

3 recalls recorded since 2018, most recently on 18 January 2019. 1 is listed as ongoing. Status and classification are as published by the FDA.

Recalls3
Ongoing (FDA)1
Terminated or completed2
Class I (FDA)0

Completed Class II Drugs

Recall started
18 January 2019
Reason
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
Distribution
Nationwide
Initiated
Voluntary: Firm initiated
Recall numbers
D-0411-2019, D-0409-2019, D-0412-2019, D-0413-2019, D-0410-2019

Ongoing Class II Drugs

Recall started
13 July 2018
Reason
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Distribution
United States
Initiated
Voluntary: Firm initiated
Recall numbers
D-0974-2018, D-0976-2018, D-0971-2018, D-0969-2018, D-0970-2018, D-0968-2018, D-0975-2018, D-0973-2018, D-0972-2018

Terminated Class II Drugs

Recall started
29 November 2017
Terminated
16 August 2019
Reason
Failed Tablet/Capsule Specifications: confirmed customer complaint of thicker and heavier tablets in bottle.
Distribution
Nationwide in the USA and Puerto Rico
Initiated
Voluntary: Firm initiated
Recall number
D-0209-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.